Articles, news and information around the cannabis sector

How is the novel food status of CBD progressing in Europe?

Written by CannIntelligence | 3rd July 2020

Several major developments have all happened at the same time for novel foods. Perhaps most importantly, one of the European Commission's departments - the Directorate-General for Health and Food Safety - has said it is holding...

Are CBD companies particularly vulnerable to advertising issues, and if so, why?

Written by CannIntelligence | 26th June 2020

CBD companies are in a fairly unique place in that they cannot use their primary function – health and wellness – to advertise their brands. And this is not without reason – as shown by...

Could subscription services boost CBD sales during times of restricted offline retail and social distancing?

Written by CannIntelligence | 18th June 2020

Subscription services do offer potential benefits to CBD companies. Those benefits come with risks, which may be managed. But the key question for anyone interested in creating such a service is whether they prefer to market...

What inference can be drawn from the Italian enforcement action against EasyJoint?

Written by CannIntelligence | 11th June 2020

The suspension of EasyJoint’s commercial activities and website pending a trial in the Italian province of Parma demonstrates that enforcement authorities intend to continue to police CBD retailers. In particular, it seems the Parma prosecutor’s office took exception...

What impact does cannabis have on bankruptcy proceedings?

Written by JuditBach | 29th May 2020

Businesses in the US should be aware of ongoing proceedings in bankruptcy courts related to companies that have been involved in cannabis. Bankruptcy filings and proceedings are unavailable to these companies as it remains an...

What implications can the industry draw from the recent Court of Justice of the European Union (CJEU) opinion in the ongoing French Kanavape case?

Written by JuditBach | 15th May 2020

France cannot stop the import of full spectrum CBD oils extracted from any part of the plant, including flowers, from other EU member states UNLESS it has scientifically established that CBD has psychotropic or toxic effects, and considered whether there were no alternative less-burdensome...

Did COVID-19 have much of an impact on 4/20 sales?

Written by JuditBach | 8th May 2020

The answer is not quite clear. A lot of companies reported no drop or even increases in sales compared to the previous year. There could be several reasons for this. Firstly, all cannabinoid-related products are...

Will COVID lead to delays in regulatory procedures?

Written by JuditBach | 1st May 2020

The ongoing pandemic lockdown looks to be ending in some areas with easing of measures in numerous jurisdictions. But the months lost – and continued social distancing measures which will not be entirely lifted in...

What aid is available for US CBD firms affected by coronavirus?

Written by JuditBach | 24th April 2020

CBD businesses in the US that have seen business impacted by the coronavirus pandemic and associated social measures could be eligible for a variety of state aid programmes. Extra funding for the programmes was just approved...

CBD-Intel: the blog

Written by CannIntelligence | 17th April 2020

CBD-Intel's own team of writers keep you up to date with background, thoughts and analysis on the whole world of CBD ...

How the COVID-19 crisis may impact the CBD market?

Written by JuditBach | 17th April 2020

Closures of non-essential retail will be far and away the largest factor impacting on CBD markets across the globe. It is estimated that up to 90% of offline sales in markets such as the UK...

LATEST ALERTS